The Food and Drug Administration () has approved the drug lecanemab, sold under the brand name Leqembi, making the US the first country in the world to approve the breakthrough medication.Developed by pharma-giants Biogen and Eisai, the drug showed ability to slow down the progression of Alzheimer's and clear plaque believed to be responsible for the disease from the brain. In clinical trials, those who received the drug saw their mental condition deteriorate 27 percent less than the control group.
Load More
Load More